Optimal oral anticoagulant therapy in patients with mechanical heart valves

New England Journal of Medicine

Volumn 333, Issue 1, 1995, Pages 11-17

  Cannegieter, S C ^a   Rosendaal, F R ^a   Wintzen, A R ^a   Van Der Meer, F J M ^a   Vandenbroucke, J P ^a   Briet, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; PHENPROCOUMON;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN EMBOLISM; BRAIN HEMORRHAGE; CLINICAL TRIAL; FEMALE; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPINAL CORD HEMORRHAGE; THROMBOEMBOLISM;

ACENOCOUMAROL; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEMORRHAGE; HUMAN; INCIDENCE; MALE; MIDDLE AGE; PHENPROCOUMON; PROTHROMBIN TIME; SUPPORT, NON-U.S. GOV'T; THROMBOEMBOLISM;

EID: 0029072271     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199507063330103     Document Type: Article

References (20)

1. Cannegieter SC, Rosendaal FR, Briet E Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641
2. Saour JN, Sieck JO, Mamo LAR, Gallus AS Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990; 322: 428-432
3. Turpie AGG, Gent M, Laupacis A, A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993; 329: 524-529
4. Altman R, Rouvier J, Gurfinkel E, Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991; 101: 427-431
5. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239
6. Duxbury BM Therapeutic quality control leading to further clinical assessment of oral anticoagulation. Acta Haematol 1986; 76: 65-67
7. Kent DL, Vermes D, McDonell M, Henikoff J, Fihn SD A model for planning optimal follow-up for outpatients on warfarin anticoagulation. Med Decis Making 1992; 12: 132-141
8. van den Besselaar AMHP, van der Meer FJM, Gerrits-Drabbe CW Therapeutic control of oral anticoagulant treatment in the Netherlands. Am J Clin Pathol 1988; 90: 685-690
9. Wiegman H, Vossepoel AM A computer program for long term anticoagulation control. Comput Methods Programs Biomed 1977; 7: 71-84
10. Vandenbroucke JP A shortcut method for calculating the 95 per cent confidence interval of the standardized mortality ratio. Am J Epidemiol 1982; 115: 303-304
11. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulation control. Thromb Haemost 1985; 53: 155-156
12. Hirsh J, Dalen JE, Deykin D, Poller L Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1992; 102: Suppl: 312S-326S
13. Stein PD, Alpert JS, Copeland J, Dalen JE, Goldman S, Turpie AGG Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1992; 102: Suppl: 445S-455S
14. DiSesa VJ, Collins JJ Jr, Cohn LH Hematological complications with the St. Jude valve and reduced-dose Coumadin. Ann Thorac Surg 1989; 48: 280-283
15. Nair CK, Mohiuddin SM, Hilleman DE, Ten-year results with the St. Jude medical prosthesis. Am J Cardiol 1990; 65: 217-225
16. Kratz JM, Crawford FA Jr, Sade RM, Crumbley AJ, Stroud MR St. Jude prosthesis for aortic and mitral valve replacement: a ten-year experience. Ann Thorac Surg 1993; 56: 462-468
17. Wilson DB, Dunn MI, Hassanein K Low-intensity anticoagulation in mechanical cardiac prosthetic valves. Chest 1991; 100: 1553-1557
18. van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E Bleeding complications in oral anticoagulant therapy: an analysis of risk factors. Arch Intern Med 1993; 153: 1557-1562
19. Fihn SD, McDonell M, Martin D, Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med 1993; 118: 511-520
20. Hylek EM, Singer DE Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120: 897-902